期刊文献+

核因子-κB抑制剂调控癌性恶病质的实验研究 被引量:4

Effect of nuclear factor-κB inhibitor on cancer cachexia
下载PDF
导出
摘要 目的:本研究旨在评价核因子-κB(NF-κB)抑制剂吡咯烷二硫代氨基甲酸盐(PDTC)对C26恶病质小鼠炎性细胞因子的合成及对恶病质的调控作用。方法:采用雄性BALB/c小鼠皮下接种C26结肠癌细胞诱导恶病质模型,每天监测小鼠食物摄入量、体质量及肿瘤体积。于接种肿瘤后第7天开始,每天给予荷瘤鼠腹腔内注射等渗盐水及不同剂量的PDTC(10、50及100 mg/kg),第16天处死小鼠,检测血生化指标、血清及肿瘤组织中IL-6水平,肿瘤组织NF-κB活性。结果:荷瘤组小鼠出现明显的组织消耗,第16天去瘤体质量为正常小鼠的71.3%(P<0.01);腓肠肌及附睾脂肪重量分别减少42.4%和70.4%(P<0.01);血清清蛋白、葡萄糖及三酰甘油水平显著下降(P<0.01);血清及肿瘤组织IL-6水平显著升高(P<0.01)。PDTC呈剂量依赖性地抑制肿瘤组织NF-κB激活,抑制肿瘤组织IL-6的合成,抑制了去瘤体质量、腓肠肌及附睾脂肪的消耗,改善了恶病质。PDTC 100 mg/kg明显抑制肿瘤生长(P<0.05)。各组间食物摄入量无明显统计学差异。结论:PDTC通过抑制肿瘤组织NF-κB的激活,抑制炎性细胞因子的合成,从而改善了恶病质。 Objective: To investigate the effect of pyrrolidine dithiocarbamate(PDTC) on IL-6 synthesis and cachexia in colon 26 tumor bearing mice.Methods: Male BALB/c mice bearing colon 26 adenocarcinoma were severed as a model of cancer cachexia.Saline and three doses of PDTC(10,50 or 100 mg/kg) were given intraperitoneally daily from 7 days after tumor inoculation to sacrifice.Body weight,food intake and tumor volume were monitored daily.Serum and tumor tissue levels of IL-6,serum biochemical indicator,and activity of NF-κB in tumor tissue were investigated in all animals. Results: Significant tissue wasting was observed in all tumor-bearing mice.By day 16,carcass weights of untreated tumor-bearing mice were about 71.3% of healthy controls(P〈0.01),and the weights of gastrocnemius muscle and epididymal fat were lowered by 42.4% and 70.4%(P〈0.01),respectively.Furthermore,tumor-bearing state caused a significant decrease of serum albumin,glucose and triglyceride(P〈0.01),and increase of IL-6(P〈0.01) in serum and tumor tissues.Administration of PDTC dose dependently inhibited the NF-κB activation in tumor tissues,inhibited IL-6 synthesis of the tumor cells,and attenuated the wasting of carcass weight,gastrocnemius muscle and epididymal fat.Tumor growth was inhibited by PDTC with 100 mg/kg(P〈0.05).No differences of food intake were found between groups(P〉0.05).Conclusion: PDTC can attenuate the development of cachexia in colon 26 tumor bearing mice through inhibition of IL-6 synthesis regulated by NF-κB.
出处 《肠外与肠内营养》 CAS 2007年第5期270-274,共5页 Parenteral & Enteral Nutrition
关键词 吡咯烷二硫代氨基甲酸盐 核因子-ΚB 恶病质 白细胞介素-6 Pyrrolidine Dithiocarbamate Nuclear factor-κB Cachexia Imterleukin-6
  • 相关文献

参考文献16

  • 1佴永军,江志伟.癌性恶病质发病机制及治疗的研究进展[J].肠外与肠内营养,2004,11(2):112-115. 被引量:1
  • 2Strassmann G,Fong M,Kenney JS,et al.Evidence for the involvement of interleukin 6 in experimental cancer cachexia[J].J Clin Invest,1992,89(5):1681-1684. 被引量:1
  • 3Kuroda K,Horiguchi Y,Nakashima J,et al.Prevention of cancer cachexia by a novel nuclear factor κB inhibitor in prostate cancer[J].Clin Cancer Res,2005,11(15):5590-5594. 被引量:1
  • 4O'Riordain MG,Falconer JS,Maingay J,et al.Peripheral blood cells from weight-losing cancer patients control the hepatic acute phase response by a primarily interleukin-6 dependent mechanism[J].Int J Oncol,1999,15(4):823-827. 被引量:1
  • 5Tanaka Y,Eda H,Tanaka T,et al.Experimental cancer cachexia induced by transplantable colon 26 adenocarcinoma in mice[J].Cancer Res,1990,50(8):2290-2295. 被引量:1
  • 6Fujita J,Tsujinaka T,Yano M,et al.Anti-interleukin-6 receptor antibody prevents muscle atrophy in colon-26 adenocarcinoma-bearing mice with modulation of lysosomal and ATP-ubiquitin-dependent proteolytic pathways[J].Int J Cancer,1996,68(5):637-643. 被引量:1
  • 7Strassmann G,Jacob CO,Evans R,et al.Mechanisms of experimental cancer cachexia.Interaction between mononuclear phagocytes and colon-26 carcinoma and its relevance to IL-6-mediated cancer cachexia[J].J Immunol,1992,148(11):3674-3678. 被引量:1
  • 8Fujiki F,Mukaida N,Hirose K,et al.Prevention of adenocarcinoma colon 26-induced cachexia by interleukin 10 gene transfer[J].Cancer Res,1997,57(1):94-99. 被引量:1
  • 9Yasumoto K,Mukaida N,Harada A,et al.Molecular analysis of the cytokine network involved in cachexia in colon 26 adenocarcinoma-bearing mice[J].Cancer Res,1995,55(4):921-927. 被引量:1
  • 10Strassmann G,Masui Y,Chizzonite R,et al.Mechanisms of experimental cancer cachexia.Local involvement of IL-1 in colon-26 tumor[J].J Immunol,1993,150(6):2341-2345. 被引量:1

二级参考文献25

  • 1[1]Grosvenor M,Balcavage L,Chlebowski RT.Symptoms potentially influcing weight loss in a cancer population[J].Cancer,1989,63(2):330-334. 被引量:1
  • 2[2]Fredrix EWHM.Energy balance in relation to cancer cachexia[J].Clin Nutr,1990, 9(6):319-324. 被引量:1
  • 3[3]Collins P,Bing C,McCulloch P et al.Muscle UCP-3 mRNA levels are elevated in weight loss associated with gastrointestinal adenocarcinoma in humans[J].Br J Cancer,2002,86(3):372-375. 被引量:1
  • 4[4]Busquets S,Sanchis D,Alvarez B et al.In the rat,tumor necrosis factor-α adminstration results in an increase in both UCP2 and UCP3 mRNA in skeletal muscle:a possible mechanism for cytokine-induced thermogenesis?[J]FEBS Lett,1998,440(3):348-350. 被引量:1
  • 5[5]Bing C,Russell ST,Beckett EE et al.Expression of uncoupling proteins-1,-2 and -3 mRNA is induced by an adenocarxinoma-derived lipid-mobilizing factor[J].Br J Cancer,2002,86(4):612-618. 被引量:1
  • 6[6]Holroyde CP,Gabuzda TG,Putnam RC et al. Altered glucose metabolism in metastatic carcinoma[J].Cancer Res,1975,35(12):3710-3714. 被引量:1
  • 7[7]Tayek JA.A review of cancer cachexia and abnormal glucose metabolism in humans with cancer[J].J AM Coll Nutr,1992,11(4):445-456. 被引量:1
  • 8[8]Rofe AM,Bourgeosis CS,Coyle P et al. Altered insulin response to glucose in weight-lossing cancer patients[J]. Anticancer Res,1994,4(2B):647-650. 被引量:1
  • 9[9]Yoshikawa T , Noguchi Y,Doi C et al. Insulin resistance in patients with cancer:relationships with tumor site, tumor stage, body-weight loss, acute-phase response, and energy expenditure [J].Nutrition,2001,17(7-8):590-593. 被引量:1
  • 10[10]Yoshikawa T , Noguchi Y,Doi C et al. Insulin resistance was connected with the alterations of substrate utilization in patients with cancer[J]. Cancer Letters,1999,141(1-2):93-98. 被引量:1

同被引文献66

  • 1陈思曾,林永堃,吕新生.吲哚美辛与沙立度胺联合治疗癌症恶病质的实验研究[J].福建医科大学学报,2005,39(1):51-53. 被引量:3
  • 2王晓斌,贾斌,赵澎涛,董明清,张莉莉,刘毅,林树新,李志超.罗红霉素对LPS诱导的肺泡巨噬细胞NF-κB活化及对TNF-α,IL-10释放的影响[J].第四军医大学学报,2005,26(5):450-453. 被引量:2
  • 3Sen R, Baltimore D. Inducibility of kappa immunoglobulin enhancer-binding protein NF-kappa B by a posttranslational mechanism [J]. Cell,1986,47(6) :921-928. 被引量:1
  • 4Thranos D, Maniatis T. NF-Kappa B : a lesson in family values[ J ]. Cell, 1995,80(4) :529-532. 被引量:1
  • 5O'Connor S, Markovina S, Miyamoto S. Evidence for a phosphorylation-independent role for Ser32 and 36 in proteasome inhibitor-resistant(PIR) IkappaBalpha degradation in B cells [ J ]. Exp Cell Res ,2005,307 ( 1 ) : 15-25. 被引量:1
  • 6Qing G, Qu Z, Xiao G. Stabilization of basally translated NF-Kappa B-inducing kinase(NIK) protein functions as a molecular switch of processing of NF-KB2 p100 [ J ]. J Biol Chem, 2005,280 (49) : 40578-40582. 被引量:1
  • 7Melstrom LG, Melstrom Jr KA, Ding XZ,et al. Mechanisms of skeletal muscle degradation and its therapy in cancer cachexia [ J ]. Histol Histopathol ;2007,22 ( 7 ) : 805-814. 被引量:1
  • 8Li YP,Reid MB. NF-kappaB mediates the protein loss induced by TNF-alpha in differentiated skeletal muscle myotubes [ J ]. Am J Physiol Requl Inteqr Comp Physiol, 2000,279 ( 4 ) : 1165-1170. 被引量:1
  • 9Smith HJ,Wyke SM,Tisdale MJ. Role of protein kinase C and NF- KB in proteolysis-inducing factor induced proteasome expression in C2C12 myotubes[ J]. Br J Cancer,2004,90(9) :1850-1857. 被引量:1
  • 10Wyke SM,Tisdale MJ. NF-KB mediates proteolysis-inducing factor induced protein degradation and expression of the ubiquitin-proteasome system in skeletal muscle[J]. Br J Cancer,2005,92(4):711-721. 被引量:1

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部